Home Page / News / Saadia Pharmaceuticals’ Team Publishes Wellbutrin XL® to Aplenzin® (Bausch Health) Cross-Over Study in Treatment-Resistant Major Depressive Disorder
Saadia Pharmaceuticals’ Team Publishes Wellbutrin XL® to Aplenzin® (Bausch Health) Cross-Over Study in Treatment-Resistant Major Depressive Disorder
